At the end of the latest market close, Amgen Inc. (AMGN) was valued at $247.14. In that particular session, Stock kicked-off at the price of $247.00 while reaching the peak value of $249.00 and lowest value recorded on the day was $246.20. The stock current value is $246.98.Recently in News on August 4, 2022, AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS. Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2022. Key results include:. You can read further details here
Amgen Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $258.45 on 04/11/22, with the lowest value was $214.39 for the same time period, recorded on 02/24/22.
Amgen Inc. (AMGN) full year performance was 8.18%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Amgen Inc. shares are logging -4.44% during the 52-week period from high price, and 24.34% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $198.64 and $258.45.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2646613 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Amgen Inc. (AMGN) recorded performance in the market was 9.78%, having the revenues showcasing 4.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 134.20B, as it employees total of 24200 workers.
Specialists analysis on Amgen Inc. (AMGN)
During the last month, 6 analysts gave the Amgen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 20 analysts were recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 244.38, with a change in the price was noted +18.13. In a similar fashion, Amgen Inc. posted a movement of +7.92% for the period of last 100 days, recording 3,080,175 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AMGN is recording 40.23 at the time of this writing. In addition, long term Debt to Equity ratio is set at 39.31.
Trends and Technical analysis: Amgen Inc. (AMGN)
Raw Stochastic average of Amgen Inc. in the period of last 50 days is set at 61.41%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 37.44%. In the last 20 days, the company’s Stochastic %K was 28.49% and its Stochastic %D was recorded 28.05%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 9.78%. Additionally, trading for the stock in the period of the last six months notably improved by 7.88%, alongside a boost of 8.18% for the period of the last 12 months. The shares increased approximately by -1.11% in the 7-day charts and went down by 0.71% in the period of the last 30 days. Common stock shares were driven by 4.61% during last recorded quarter.